Please login to the form below

Not currently logged in

Astellas opens new office in Dubai

Will support operations in the Middle East, North and Sub-Saharan Africa
Burj Khalifa and Dubai downtown at dusk

Astellas has announced the opening of a new regional office in Dubai to support its growing business operations in the Middle East, North and Sub-Saharan Africa.

The new MENA/SS office will serve as a management hub and platform to expand and develop business activities in countries across the area. Europe, the Middle East and Africa contribute around a quarter of the firm's global profit and sales.

The new affiliate will be lead by general manager Markus Weber, who said: “The UAE was the natural choice for our regional affiliate office because of its unparalleled infrastructure and the huge pool of talent from across the territory.

“We have already established a team of highly skilled people, with local knowledge and long-standing professional experience in the region and plan to develop and expand our workforce as our business grows.”

A key priority for the Dubai-based team will be to ensure more patients in the region can access the company's growing portfolio of innovative cancer treatments.

Yoshihiko Hatanaka, president and CEO of Astellas, commented: “Our sustained financial success and strong sales growth means that we can invest heavily in cutting-edge research and development, supporting the patients and doctors we serve by producing innovative new medicines in areas like oncology where there is a vital need for improved treatments.”

Investments over the next three years will primarily focus on expanding and developing individual country organisations, with long-term strategies driving clinical research across the territory.

21st November 2014

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...